'Smoking Genes': A genetic association study

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Verde, Zoraida ^a   Santiago, Catalina ^a   González Moro, José Miguel Rodríguez ^b   de Lucas Ramos, Pilar ^b   Martín, Soledad López ^b   Bandrés, Fernando ^c   Lucia, Alejandro ^a   Gómez Gallego, Félix ^a  

^a UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c Fundación Tejerina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; NICOTINE; THYMINE; COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; UNSPECIFIC MONOOXYGENASE;

5HTT LPR GENE; ADULT; AGED; ALLELE; ARTICLE; CHRNA3 GENE; CHRNA5 GENE; CIGARETTE SMOKING; CNR1 GENE; COHORT ANALYSIS; CONTROLLED STUDY; CYP2A13 GENE; CYP2A6 GENE; CYP2B6 GENE; DNA POLYMORPHISM; DRD2 ANKK1 GENE; ETHNIC GROUP; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HTR2A GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; OPRM1 GENE; PHENOTYPE; SMOKING HABIT; SPANISH; TOBACCO DEPENDENCE; WILD TYPE; BRAIN LEVEL; CASE CONTROL STUDY; GENETICS; SMOKING; SPAIN;

ARYL HYDROCARBON HYDROXYLASES; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; NICOTINE; PHENOTYPE; SMOKING; SPAIN; TOBACCO USE DISORDER;

EID: 80055025824     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026668     Document Type: Article

References (47)

1. Murray S, (2006) A smouldering epidemic. CMAJ 174 (3): 309-310.
2. Hughes JR, Stead LF, Lancaster T, (2007) Antidepressants for smoking cessation. 1 Cochrane Database Syst Rev.
3. Silagy C, Lancaster T, Stead L, Mant D, Fowler G, (2002) Nicotine replacement therapy for smoking cessation. 4 Cochrane Database Syst Rev.
4. Xian H, Scherrer JF, Eisen SA, Lyons MJ, Tsuang M, et al. (2007) Nicotine dependence subtypes: Association with smoking history, diagnostic criteria and psychiatric disorders in 5440 regular smokers from the vietnam era twin registry. Addict Behav 32 (1): 137-147.
5. John U, Meyer C, Hapke U, Rumpf HJ, Schumann A, (2004) Nicotine dependence, quit attempts, and quitting among smokers in a regional population sample from a country with a high prevalence of tobacco smoking. Prev Med 38 (3): 350-358.
6. Carmelli D, Swan GE, Robinette D, Fabsitz R, (1992) Genetic influence on smoking-a study of male twins. N Engl J Med 327 (12): 829-833.
7. Kendler KS, Thornton LM, Pedersen NL, (2000) Tobacco consumption in swedish twins reared apart and reared together. Arch Gen Psychiatry 57 (9): 886-892.
8. Li MD, Cheng R, Ma JZ, Swan GE, (2003) A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98 (1): 23-31.
9. Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, et al. (2004) Defining nicotine dependence for genetic research: Evidence from australian twins. Psychol Med 34 (5): 865-879.
10. Broms U, Silventoinen K, Madden PA, Heath AC, Kaprio J, (2006) Genetic architecture of smoking behavior: A study of finnish adult twins. Twin Res Hum Genet 9 (1): 64-72.
11. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, et al. (2007) Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16 (1): 24-35.
12. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, et al. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16 (1): 36-49.
13. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, et al. (2007) Molecular genetics of nicotine dependence and abstinence: Whole genome association using 520,000 SNPs. BMC Genet 8: 10.
14. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452 (7187): 638-642.
15. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, et al. (2008) Molecular genetics of successful smoking cessation: Convergent genome-wide association study results. Arch Gen Psychiatry 65 (6): 683-693.
16. Drgon T, Johnson C, Walther D, Albino AP, Rose JE, et al. (2009) Genome-wide association for smoking cessation success: Participants in a trial with adjunctive denicotinized cigarettes. Mol Med 15 (7-8): 268-274.
17. Drgon T, Montoya I, Johnson C, Liu QR, Walther D, et al. (2009) Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol Med 15 (1-2): 21-27.
18. Lerman CE, Schnoll RA, Munafo MR, (2007) Genetics and smoking cessation improving outcomes in smokers at risk. Am J Prev Med 33 (6 Suppl): S398-405.
19. Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE, (2008) Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 75 (1): 178-195.
20. Fagerstrom KO, Schneider NG, (1989) Measuring nicotine dependence: A review of the fagerstrom tolerance questionnaire. J Behav Med 12 (2): 159-182.
21. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, et al. NCI-NHGRI Working Group on Replication in Association Studies (2007) Replicating genotype-phenotype associations. Nature 447 (7145): 655-660.
22. Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF, (2004) Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult caucasians. Pharmacogenetics 14 (9): 615-626.
23. Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, et al. (2000) Duplications and defects in the CYP2A6 gene: Identification, genotyping, and in vivo effects on smoking. Mol Pharmacol 58 (4): 747-755.
24. Oscarson M, (2001) Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: Implications for interindividual differences in nicotine metabolism. Drug Metab Dispos 29 (2): 91-95.
25. Pianezza ML, Sellers EM, Tyndale RF, (1998) Nicotine metabolism defect reduces smoking. Nature 393 (6687): 750.
26. Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, et al. (2006) Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Mol Psychiatry 11 (4): 400-409.
27. Malaiyandi V, Sellers EM, Tyndale RF, (2005) Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther 77 (3): 145-158.
28. Pomerleau OF, (1995) Individual differences in sensitivity to nicotine: Implications for genetic research on nicotine dependence. Behav Genet 25 (2): 161-177.
29. O'Loughlin J, Paradis G, Kim W, DiFranza J, Meshefedjian G, et al. (2004) Genetically decreased CYP2A6 and the risk of tobacco dependence: A prospective study of novice smokers. Tob Control 13 (4): 422-428.
30. Noble EP, Syndulko K, Fitch RJ, Ritchie T, Bohlman MC, et al. (1994) D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol 29 (6): 729-744.
31. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, et al. (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3 (3): 256-260.
32. Johnstone E, Benowitz N, Cargill A, Jacob R, Hinks L, et al. (2006) Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther 80 (4): 319-330.
33. Munafo MR, Johnstone EC, Murphy MF, Aveyard P, (2009) Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial. Nicotine Tob Res 11 (4): 404-407.
34. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ, (1993) Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621 (2): 311-318.
35. Polina ER, Contini V, Hutz MH, Bau CH, (2009) The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug Alcohol Depend 101 (1-2): 128-131.
36. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, et al. (2008) Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165 (9): 1163-1171.
37. Chen X, Williamson VS, An SS, Hettema JM, Aggen SH, et al. (2008) Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry 65 (7): 816-824.
38. Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, et al. (2008) Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behav Pharmacol 19 (5-6): 641-649.
39. Nilsson KW, Oreland L, Kronstrand R, Leppert J, (2009) Smoking as a product of gene-environment interaction. Ups J Med Sci 114 (2): 100-107.
40. Lerman C, Shields PG, Audrain J, Main D, Cobb B, et al. (1998) The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 7 (3): 253-255.
41. Terayama H, Itoh M, Fukunishi I, Iwahashi K, (2004) The serotonin-2A receptor polymorphism and smoking behavior in japan. Psychiatr Genet 14 (4): 195-197.
42. Zhang L, Kendler KS, Chen X, (2006) The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct 2: 28.
43. Maes HH, Neale MC, Chen X, Chen J, Prescott CA, et al. (2011) A twin association study of nicotine dependence with markers in the CHRNA3 and CHRNA5 genes. Behav Genet.
44. Kandel DB, Kiros GE, Schaffran C, Hu MC, (2004) Racial/ethnic differences in cigarette smoking initiation and progression to daily smoking: A multilevel analysis. Am J Public Health 94 (1): 128-135.
45. Wang J, Li MD, (2010) Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. Neuropsychopharmacology 35 (3): 702-719.
46. Attia J, Ioannidis JP, Thakkinstian A, McEvoy M, Scott RJ, et al. (2009) How to use an article about genetic association: B: Are the results of the study valid? JAMA 301 (2): 191-197.
47. Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ, (2009) Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur Respir J 33 (3): 468-480.